| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |